Boehringer Ingelheim International GmbH - Company Profile
Powered by 
All the sales intelligence you need on Boehringer Ingelheim International GmbH in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Boehringer Ingelheim International GmbH fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Boehringer Ingelheim International GmbH.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Boehringer Ingelheim International GmbH (Boehringer Ingelheim), a subsidiary of CH Boehringer Sohn AG & Co KG, is an innovative research-based pharmaceutical company that discovers, develops, and markets novel products of high therapeutic value for human and veterinary use. Robust R&D activities, production capabilities, and revenue growth are its strengths even as dependency on key markets could be a major cause for concern for the company. Boehringer Ingelheim could benefit from the leveraging global market growth, launch of new products, and contracts and agreements which provide growth opportunities for the company. However, adverse or inconclusive results from preclinical testing or clinical trials, influx of generics, and government regulations could affect the company's operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer